Trilaciclib Combing Chemotherapy in the Neoadjuvant Treatment of Osteosarcoma
Clinical trial NCT06714383 · RECRUITING
Trial details
- NCT number
- NCT06714383
- Sponsor
- Peking University People's Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-13
- Primary completion
- 2025-07-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.